MARKET

DRIO

DRIO

DarioHealth
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.81
+0.17
+1.16%
After Hours: 15.68 +0.87 +5.87% 18:56 05/18 EDT
OPEN
14.66
PREV CLOSE
14.64
HIGH
16.51
LOW
14.58
VOLUME
403.77K
TURNOVER
--
52 WEEK HIGH
31.85
52 WEEK LOW
5.55
MARKET CAP
229.19M
P/E (TTM)
-2.1661
1D
5D
1M
3M
1Y
5Y
DarioHealth Scoops Up Digital Behavioral Health Platform For $30M
Benzinga · 13h ago
DarioHealth acquires digital behavioral health platform wayForward
DarioHealth (DRIO) has entered into an agreement to acquire behavioral health digital platform PsyInnovations (dba wayForward).Under the terms of the merger agreement, Dario has agreed to pay a consideration of $30M, with
Seekingalpha · 14h ago
DarioHealth Acquires Digital Behavioral Health Platform wayForward
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has entered into an agreement to acquire PsyInnovations, Inc. (dba wayForward), a behavioral health digital platform that includes AI-enabled screenin...
PR Newswire · 15h ago
DarioHealth Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 18, 2021 / DarioHealth Corp. (NASDAQ:DRIO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 18, 2021 at 8:30 AM Eastern Time.
ACCESSWIRE · 16h ago
DarioHealth Signs Deal to Buy Behavioral Health Platform wayForward for $30 Million
MT Newswires · 18h ago
DarioHealth EPS beats by $0.18, misses on revenue
DarioHealth (DRIO): Q1 GAAP EPS of -$0.92 beats by $0.18.Revenue of $3.6M (+114.3% Y/Y) misses by $0.2M.Press Release
Seekingalpha · 1d ago
DarioHealth Reports First Quarter 2021 Results and Operational Highlights
, /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided a corporate and commercial update.
PR Newswire - PRF · 1d ago
DarioHealth Q1 Loss Shrinks as Revenue Rises
MT Newswires · 1d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of DRIO. Analyze the recent business situations of DarioHealth through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average DRIO stock price target is 28.78 with a high estimate of 35.00 and a low estimate of 18.25.
EPS
Institutional Holdings
Institutions: 59
Institutional Holdings: 5.99M
% Owned: 38.71%
Shares Outstanding: 15.48M
TypeInstitutionsShares
Increased
11
301.47K
New
24
2.60M
Decreased
6
400.81K
Sold Out
5
424.16K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.39%
Healthcare Equipment & Supplies
+0.35%
Key Executives
Chairman/Independent Director
Yoav Shaked
President/General Manager
Richard Anderson
Chief Executive Officer/Director
Erez Raphael
Chief Financial Officer/Treasurer/Secretary
Zvi Ben-David
Chief Operating Officer
Dror Bacher
Senior Vice President/Director of Sales
Chris Chan
Senior Vice President
Olivier Jarry
Senior Vice President
Barbara Stark
Vice President
Claudia Kraut
Other
Omar Manejwala
Director
Dennis Matheis
Director
Adam Stern
Independent Director
Allen Kamer
Independent Director
Hila Karah
Independent Director
Dennis McGrath
Independent Director
Dennis Mcgrath
Independent Director
Yadin Shemmer
Independent Director
Richard Stone
No Data
About DRIO
DarioHealth Corp. (DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The DTx products are centered around its users and include the Dario Blood Glucose Monitoring System and the Dario Smart Diabetes Management Solution, which are provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports; the DarioEngage platform, which provides support and two-way real-time connectivity between its users and their caregivers, and Dario Intelligence, which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases. The Company’s services are available direct to consumers via online marketplaces including Amazon, Walmart, Best Buy and the Google and Apple app stores.

Webull offers kinds of DarioHealth Corp stock information, including NASDAQ:DRIO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DRIO stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading DRIO stock methods without spending real money on the virtual paper trading platform.